Scheid Vineyards (OTCMKTS:SVIN – Get Free Report) and Yield10 Bioscience (NASDAQ:YTEN – Get Free Report) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and profitability.
Analyst Ratings
This is a summary of current ratings and price targets for Scheid Vineyards and Yield10 Bioscience, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Scheid Vineyards | 0 | 0 | 0 | 0 | N/A |
| Yield10 Bioscience | 0 | 0 | 0 | 0 | N/A |
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Scheid Vineyards | -3.22% | N/A | N/A |
| Yield10 Bioscience | -3,882.82% | -243.41% | -143.90% |
Insider and Institutional Ownership
7.8% of Yield10 Bioscience shares are held by institutional investors. 9.6% of Scheid Vineyards shares are held by company insiders. Comparatively, 5.3% of Yield10 Bioscience shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Scheid Vineyards and Yield10 Bioscience’s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Scheid Vineyards | $69.25 million | 0.20 | -$2.23 million | ($2.43) | -6.21 |
| Yield10 Bioscience | $450,000.00 | 25.58 | -$13.57 million | ($2.84) | -0.67 |
Scheid Vineyards has higher revenue and earnings than Yield10 Bioscience. Scheid Vineyards is trading at a lower price-to-earnings ratio than Yield10 Bioscience, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Scheid Vineyards has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500. Comparatively, Yield10 Bioscience has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500.
Summary
Scheid Vineyards beats Yield10 Bioscience on 7 of the 11 factors compared between the two stocks.
About Scheid Vineyards
Scheid Vineyards Inc. manufactures and sells wine in the United States. The company operates vineyards in Monterey and San Benito counties of California. It offers red, white, reserve, dessert wines, as well as accessories, such as wine glass. The company was incorporated in 1971 and is based in Salinas, California.
About Yield10 Bioscience
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
Receive News & Ratings for Scheid Vineyards Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scheid Vineyards and related companies with MarketBeat.com's FREE daily email newsletter.
-logo.jpg?v=20230511062707&h=45&w=95&zc=2){kind=logo}
